GB2270293A — Drug dispensing system
Assigned to Medix Ltd · Expires 1994-03-09 · 32y expired
What this patent protects
A drug capsule (10) comprising a sleeve (12) whose open ends are closed by a pair of opposite end caps (16, 18) which are displacably connected to the sleeve. The end faces (22, 30) of the end caps are frangible so that they can be ruptured by the open ends of the sleeve by causi…
USPTO Abstract
A drug capsule (10) comprising a sleeve (12) whose open ends are closed by a pair of opposite end caps (16, 18) which are displacably connected to the sleeve. The end faces (22, 30) of the end caps are frangible so that they can be ruptured by the open ends of the sleeve by causing the end caps to be displaced along the sleeve towards one another to open the capsule. An inhalation device for use with a drug capsule with frangible end caps comprises a mouth piece (212) and a tail piece (214) adapted to receive between them in a chamber defined by the interengaged pieces (212, 214) such a drug capsule (210). The mouth piece (212) and the tail piece (214) each comprise abutment faces for stops on the end caps (16, 18) of a drug capsule. When the two pieces (12, 14) are pushed together, so are the end caps, which are thereby ruptured by the ends of the sleeve 12.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.